CSHL1 gene – Talk Bio

GSK, Sanofi, and CSL Secure $72 Million BARDA Funding to Enhance Bird Flu Vaccine Supply

7 months ago talkbio0Tagged BARDA, bird flu vaccine, CSHL1 gene, public health medicine (field), sanofi, SmithKline Beecham, Vaccines

BARDA funding, bird flu vaccine, GSK, Sanofi, CSL, vaccine supply, public health

CSL Seqirus Secures Fourth US Award to Enhance Bird Flu Vaccine Stockpile

11 months ago talkbio0Tagged Aves, BARDA, bird flu vaccine, CSHL1 gene, Government, Influenza in Birds, pandemic preparedness, public health protection, Seqirus, U.S., Vaccines

CSL Seqirus, bird flu vaccine, US government award, BARDA, pandemic preparedness, avian influenza, H5N1, vaccine stockpile, public health protection

CSL Vifor’s Corrective Marketing Initiative to Address Anti-Competitive Concerns

1 year ago talkbio0Tagged anti-competitive practices, competition, Corrective, CSHL1 gene, Drug Industry, fairness, Market, Measures, Vifor

CSL Vifor, marketing campaign, anti-competitive practices, competition law, corrective measures, pharmaceutical industry, competition watchdog, market fairness.

CSL Vifor Proposes Corrective Campaign to Resolve EU Antitrust Probe

1 year ago talkbio0Tagged Antitrust Probe, competition, Corrective Campaign, CSHL1 gene, EU, Multi-Channel Communication, Vifor

CSL Vifor, EU Antitrust Probe, Corrective Campaign, Multi-Channel Communication, Competition